AMETEK (NYSE:AME) Stock, Quote.Headers.trade-ideas

AMETEK

Ametek Inc is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets, and generates major revenue. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. The majority of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.

Earnings

Earnings Beats

News

Small Cap

Markets

Analyst Ratings

Trading Ideas

ASPN

GDDY

AMETEK, Inc. (NYSE: AME) is scheduled to report second-quarter 2024 results on Aug 1.

AMETEK to Report Q2 Earnings: What&#39;s in the Offing?

JimCramer.Shutterstock

Media

MNMD

MRNA

PLTR

Regarding Hertz, Jim Cramer said, &#34;I don&#39;t want you to sell, and I don&#39;t want you to double down. Let&#39;s just see if it can&#39;t go higher.&#34;

Jim Cramer: This Industrial Company Is &#39;Absolutely Terrific&#39;, Recommends Buying Modine Manufacturing

Equities

Large Cap

Guidance

Electronic Instruments Maker AMETEK Buys Paragon Medical For $1.9B Cash; Raises FY23 EPS Outlook

AMETEK Inc

AME Chain

Amedisys Inc

AMERICAN EAGLE GOLD CORP by AMERICAN EAGLE GOLD CORP.

American Eagle Gold Corp

AMEN PROPERTIES INC by AMEN Properties, Inc.

AMEN Properties Inc

ANTERIS TECHNOLOGIES LTD by Anteris Technologies Ltd.

Anteris Technologies Ltd

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 15 years by 5.48% on an annualized basis producing an average annual return of 17.06%. Currently, AMETEK has a market capitalization of $37.89 billion. 
Buying $100 In AME: If an investor had bought $100 of AME stock 15 years ago, it would be worth $1,071.46 today based on a price of $163.64 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725901216_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In AMETEK 15 Years Ago Would Be Worth Today

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 20 years by 7.52% on an annualized basis producing an average annual return of 15.97%. Currently, AMETEK has a market capitalization of $38.17 billion. 
Buying $100 In AME: If an investor had bought $100 of AME stock 20 years ago, it would be worth $1,920.85 today based on a price of $164.86 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724250623_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In AMETEK 20 Years Ago Would Be Worth This Much Today

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 20 years by 7.61% on an annualized basis producing an average annual return of 15.86%. Currently, AMETEK has a market capitalization of $37.39 billion. 
Buying $100 In AME: If an investor had bought $100 of AME stock 20 years ago, it would be worth $1,871.32 today based on a price of $161.50 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723474818_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Baird analyst Richard Eastman maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Neutral and lowers the price target from $171 to $166.

Price Target

Baird Maintains Neutral on AMETEK, Lowers Price Target to $166

TD Cowen analyst Joseph Giordano maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Hold and lowers the price target from $165 to $158.

TD Cowen Maintains Hold on AMETEK, Lowers Price Target to $158

RBC Capital analyst Deane Dray maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Outperform and lowers the price target from $216 to $215.

RBC Capital Maintains Outperform on AMETEK, Lowers Price Target to $215

WIIM

ALTG

ARIS

ARRY

ASLE

ATKR

AXON

CAAP

CAPT

CARR

CDLR

CHRW

CMPR

CNTM

DRVN

Embraer-Empresa Brasileira De Aeronautica

EVEX

EXPD

FLNC

FTAI

FWRD

GWAV

HUBB

HYLN

HYZN

JOBY

LICN

MYRG

NCNC

NKLA

NVRI

PRIM

REZI

ROCK

RUSHA

RUSHB

SHLS

STAF

TFII

TOMZ

TPIC

ULCC

WLFC

XPON

Shares of companies within the broader industrial sector are trading lower amid overall market weakness following weak US data.

4 analysts have expressed a variety of opinions on AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $194.0, a high estimate of $204.00, and a low estimate of $171.00. A 0.85% drop is evident in the current average compared to the previous average price target of $195.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1722603614_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of AMETEK by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$201.00</td>
<td>$204.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$204.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Christopher Glynn</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$200.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$171.00</td>
<td>$173.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to AMETEK. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of AMETEK compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of AMETEK's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of AMETEK's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/AME/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on AMETEK analyst ratings.</a>
<h2>Delving into AMETEK's Background</h2>
Ametek Inc is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets, and generates major revenue. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. The majority of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
<h3>AMETEK: Financial Performance Dissected</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining AMETEK's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.71% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 17.91%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): AMETEK's ROE stands out, surpassing industry averages. With an impressive ROE of 3.51%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): AMETEK's ROA excels beyond industry benchmarks, reaching 2.08%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.33, AMETEK adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For AMETEK

Truist Securities analyst Jamie Cook maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Buy and lowers the price target from $204 to $201.

Truist Securities Maintains Buy on AMETEK, Lowers Price Target to $201

AMETEK shares are trading lower after the company reported mixed Q2 financial results and cut its FY24 adjusted EPS guidance below estimates.

AMETEK Now Expects FY24 Overall Sales To Be Up 5% - 7% (Prior View Up Low Double Digits); Cuts Adjusted EPS Forecast From $6.74 - $6.86 To $6.70 - $6.80, Est $6.84

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) reported quarterly earnings of $1.66 per share which beat the analyst consensus estimate of $1.64 by 1.22 percent. This is a 5.73 percent increase over earnings of $1.57 per share from the same period last year. The company reported quarterly sales of $1.734 billion which missed the analyst consensus estimate of $1.784 billion by 2.78 percent. This is a 5.35 percent increase over sales of $1.646 billion the same period last year.

Earnings Misses

AMETEK Q2 2024 Adj. EPS $1.66 Beats $1.64 Estimate, Sales $1.734B Miss $1.784B Estimate

AMETEK, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ame#NYSE">AME</a>) is scheduled to report second-quarter 2024 results on Aug 1.
For the second quarter, AMETEK expects sales growth in the mid to high-single digits from the year-ago quarter&#39;s reported figure. The Zacks Consensus Estimate for sales is pegged at $1.77 billion, suggesting an increase of 7.8% from the year-ago quarter&#39;s reported figure.
AMETEK expects adjusted earnings of $1.63-$1.65 per share, suggesting growth of 4-5% from the year-ago quarter&#39;s reported number. The Zacks Consensus Estimate for earnings is pinned at $1.64 per share, implying growth of 4.5% from the prior-year quarter&#39;s reported numbers.
AME&#39;s earnings beat estimates in each of the trailing four quarters, the average being 3.48%.
Let&#39;s see how things have shaped up for the upcoming announcement.
<div class="chart_embed">
<h3>AMETEK, Inc. Price and EPS Surprise</h3>
<img alt="AMETEK, Inc. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/f0/1722266053.png" style="height:299px; width:620px" title="" />
AMETEK, Inc. price-eps-surprise | AMETEK, Inc. Quote
</div>
<h3>Key Factors to Note</h3>
AMETEK&#39;s second-quarter 2024 performance is expected to have benefited from solid momentum across the Electromechanical Group (EMG) segment, owing to positive contributions from Paragon Medical and Bison Engineering acquisitions.
The Zacks Consensus Estimate for second-quarter EMG sales is pinned at $603.96 million, indicating 18.1% growth from the year-ago quarter&#39;s reported figure.
Strength in the Electronic Instruments Group segment on the back of benefits from Navitar, Alphasense, Magnetrol International and Crank Software buyouts and strong momentum across aerospace &amp; defense and materials analysis businesses is likely to have boosted the company&#39;s performance in the second quarter.
The Zacks Consensus Estimate for second-quarter EIG sales is pegged at $1.17 billion, indicating growth of 3.2% from the year-ago quarter&#39;s reported figure.
Increasing demand for AMETEK&#39;s solutions across high-growth markets, including med tech, clean energy and electrification, is expected to have acted as a tailwind.
AME&#39;s proper execution of its core growth strategies, including operational excellence, global market expansion and investments in product development and acquisitions, is expected to have driven the second-quarter performance.
The impacts of strengthening momentum across the AMETEK Growth Model are expected to get reflected in the to-be-reported quarter&#39;s results.
However, high goodwill associated with aggressive acquisition strategies and the impacts of rising geopolitical tensions are expected to have been headwinds for the company.
Macroeconomic uncertainties and unfavorable foreign exchange fluctuations are expected to have been concerns.
<h3>What Our Model Says</h3>
According to the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that&#39;s not the case here.
AMETEK currently has an Earnings ESP of -0.61% and a Zacks Rank #3.
<h3>Stocks to Consider</h3>
Here are some stocks worth considering, as our model shows that they have the right combination of elements to beat on earnings this season.
Aspen Aerogels (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aspn#NYSE">ASPN</a>) has an Earnings ESP of +23.53% and sports a Zacks Rank #1 at present.
Aspen Aerogels is set to report its second-quarter 2024 results on Aug 7. The Zacks Consensus Estimate for ASPN&#39;s earnings is pegged at 5 cents per share, indicating a significant jump from the prior-year quarter&#39;s loss of 22 cents per share.
Apple&nbsp;has an Earnings ESP of +3.05% and a Zacks Rank #2 at present.
Apple is scheduled to release third-quarter fiscal 2024 results on Aug 1. The Zacks Consensus Estimate for AAPL&#39;s earnings is pegged at $1.33 per share, suggesting a jump of 5.6% from the prior-year quarter.
GoDaddy (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gddy#NYSE">GDDY</a>) has an Earnings ESP of +13.08% and a Zacks Rank #3 at present.
GoDaddy is set to report second-quarter 2024 results on Aug 1. The Zacks Consensus Estimate for GDDY&#39;s earnings is pegged at $1.07 per share, indicating growth of 69.8% from the year-ago quarter&#39;s reported figure.
<a href="https://www.zacks.com/stock/news/2311207/ametek-ame-to-report-q2-earnings-what-s-in-the-offing?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2311207">To read this article on Zacks.com click here.</a>

AMETEK to Report Q2 Earnings: What's in the Offing?

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 10 years by 2.14% on an annualized basis producing an average annual return of 13.05%. Currently, AMETEK has a market capitalization of $40.04 billion. 
Buying $1000 In AME: If an investor had bought $1000 of AME stock 10 years ago, it would be worth $3,362.56 today based on a price of $172.97 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721683825_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In AMETEK 10 Years Ago Would Be Worth This Much Today

AMETEK's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) short percent of float has fallen 34.26% since its last report. The company recently reported that it has 2.92 million shares sold short, which is 1.42% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.28 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AMETEK Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721322920_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AMETEK has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AMETEK's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AMETEK's peer group average for short interest as a percentage of float is 11.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(AME) - Analyzing AMETEK's Short Interest

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 20 years by 7.24% on an annualized basis producing an average annual return of 15.63%. Currently, AMETEK has a market capitalization of $38.34 billion. 
Buying $1000 In AME: If an investor had bought $1000 of AME stock 20 years ago, it would be worth $18,267.49 today based on a price of $165.65 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720452613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In AMETEK 20 Years Ago Would Be Worth This Much Today

Truist Securities analyst Jamie Cook maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Buy and lowers the price target from $210 to $204.

Truist Securities Maintains Buy on AMETEK, Lowers Price Target to $204

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 10 years by 1.32% on an annualized basis producing an average annual return of 12.18%. Currently, AMETEK has a market capitalization of $38.66 billion. 
Buying $1000 In AME: If an investor had bought $1000 of AME stock 10 years ago, it would be worth $3,127.89 today based on a price of $167.02 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1718645414_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,100 Today

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 15 years by 4.89% on an annualized basis producing an average annual return of 17.03%. Currently, AMETEK has a market capitalization of $38.34 billion. 
Buying $100 In AME: If an investor had bought $100 of AME stock 15 years ago, it would be worth $1,068.22 today based on a price of $165.65 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1717509619_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 15 Years Ago Would Be Worth $1,100 Today

Ratings for AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $196.5, a high estimate of $210.00, and a low estimate of $171.00. This upward trend is apparent, with the current average reflecting a 10.7% increase from the previous average price target of $177.50.
<img src="https://www.benzinga.com/files/images/story/2024/1716379272_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of AMETEK among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Christopher Glynn</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$200.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$171.00</td>
<td>$173.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$210.00</td>
<td>-</td>
</tr>
<tr>
<td>Steve Barger</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$205.00</td>
<td>$182.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to AMETEK. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AMETEK compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of AMETEK's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of AMETEK's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AME/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on AMETEK analyst ratings.</a>
<h2>Get to Know AMETEK Better</h2>
Ametek Inc is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets, and generates major revenue. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. The majority of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
<h3>Financial Milestones: AMETEK's Journey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3 months period, AMETEK showcased positive performance, achieving a revenue growth rate of 8.71% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: AMETEK's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 17.91% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): AMETEK's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.51%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.08%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.33, AMETEK adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Key Takeaways From AMETEK Analyst Ratings

Bank of America Securities analyst Andrew Obin maintained a Hold rating on Ametek (AME – Research Report) today. The company's shares opened today ...

Bank of America Securities Keeps Their Hold Rating on Ametek (AME)

TD Cowen analyst Joseph C Giordano maintained a Hold rating on Ametek (AME – Research Report) today and set a price target of $158.00. Joseph C Gio...

Ametek: Hold Rating Justified by Cautious Financial Outlook and Market Valuation

Ametek declares $0.28 dividend

AMR Update - Mid-2024

Tracking Mario Gabelli's Gabelli Funds 13F Portfolio - Q2 2024 Update

IDE: Gain Exposure To Electric Consumption Growth With This 11.27%-Yielding Fund

Dividend Champion, Contender, And Challenger Highlights: Week Of September 8

Ametek: Headwinds Likely To Persist Into 2025

In a report released today, Christopher Glynn from Oppenheimer maintained a Buy rating on Ametek (AME – Research Report), with a price target of $1...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

AMETEK

AMETEK (AME) Forecast

AMETEK (NYSE:AME) Stock, Quote.Headers.trade-ideas